Cabot Corp. (CBT) Tops Q4 EPS by 17c
Tweet
Share
E-mail
Get Alerts CBT Hot Sheet
Price: $80.55 -1.14%
EPS Growth %: -10.0%
Financial Fact:
Cost of sales: 450M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -10.0%
Financial Fact:
Cost of sales: 450M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cabot Corp. (NYSE: CBT) reported Q4 EPS of $1.65, $0.17 better than the analyst estimate of $1.48. Revenue for the quarter came in at $965 million versus the consensus estimate of $991.48 million.
For earnings history and earnings-related data on Cabot Corp. (CBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Labcorp acquires MLM Medical Labs to expand lab network
- MSC Industrial names Rob Kuhns as executive VP and CFO
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
